Euphorbia hirta extracts demonstrate in vitro antimicrobial activity and potential resistance-modifying effects against ESKAPE pathogens
Plant extract shows potential against drug-resistant bacteria
This systematic review of 27 peer-reviewed articles evaluates the in vitro antimicrobial potential of Euphorbia hirta extracts against criti…
A plant called Euphorbia hirta may help weaken the defenses of some of the world's most dangerous, drug-resistant bacteria.
Cefepime-nacubactam and aztreonam-nacubactam non-inferior for complicated UTI and pyelonephritis
New antibiotics show promise for complicated urinary tract infections
This phase 3 randomised double-blind study in adults with complicated urinary tract infection or acute uncomplicated pyelonephritis found ce…
A large trial found new antibiotic combinations worked better than standard care for certain urinary infections in adults.
Systematic review and meta-analysis compares piperacillin-tazobactam and cefepime in pediatric febrile neutropenia
Two Antibiotics for Fever in Kids: One Works a Day Faster
This systematic review and meta-analysis evaluates piperacillin-tazobactam versus cefepime monotherapy in 470 episodes of pediatric febrile …
When a child on chemotherapy gets a fever, doctors have two main antibiotic choices, and a new analysis of 470 cases shows they work equally…
FDA Approves Cefepime for Injection and Dextrose Injection (cefepime) for Moderate to Severe Pneumonia and Other Infections
The FDA approved a new ready-to-use version of an antibiotic called cefepime for serious infections
The FDA approved cefepime in a dextrose injection formulation for intravenous treatment of moderate to severe pneumonia, febrile neutropenia…
The FDA approved a ready-to-use antibiotic for serious infections like pneumonia and urinary tract infections in hospitalized patients.